Carman Alenson

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Ryan Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carman Alenson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. SVP, Finance and Chief Accounting Officer Stock Option (right to buy) 140,000 23 Feb 2026 Direct
AGIOS PHARMACEUTICALS, INC. Principal Accounting Officer Stock option (right to buy) 3,555 21 Jun 2021 Direct
AGIOS PHARMACEUTICALS, INC. Principal Accounting Officer Common stock 0 $21.64 21 Jun 2021 Direct

Insider Reports Filed by Carman Alenson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRME Prime Medicine, Inc. 23 Feb 2026 1 $0 4 SVP, Finance and Chief Accounting Officer 24 Feb 2026, 16:58
PRME Prime Medicine, Inc. 01 Aug 2025 8 $0 4 Exhibit 24 - Power of Attorney 05 Aug 2025, 20:42
PRME Prime Medicine, Inc. 27 Feb 2025 1 $0 4 SVP, Finance and Chief Accounting Officer 03 Mar 2025, 20:18
PRME Prime Medicine, Inc. 21 Feb 2024 1 $0 4 SVP, Finance and Chief Accounting Officer 23 Feb 2024, 17:01
PRME Prime Medicine, Inc. 18 Apr 2023 1 $0 4 Officer 20 Apr 2023, 16:28
PRME Prime Medicine, Inc. 31 Mar 2023 1 $0 4 Interim Chief Financial Officer and Chief Accounting Officer 04 Apr 2023, 20:22
PRME Prime Medicine, Inc. 19 Oct 2022 0 $0 3 Interim Chief Financial Officer and Chief Accounting Officer. Exhibit 24 - Power of Attorney 19 Oct 2022, 20:05
AGIO AGIOS PHARMACEUTICALS, INC. 21 Jun 2021 3 -$17,948 4 Principal Accounting Officer 23 Jun 2021, 17:28